Jove
Visualize
Contact Us

Related Concept Videos

Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Covid-19 Vaccine Collaborative Supply Planning: Is This The Next Frontier For Routine Immunization Supply Chains?
  1. Home
  3. Covid-19 Vaccine Collaborative Supply Planning: Is This The Next Frontier For Routine Immunization Supply Chains?

Related Experiment Video

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.2K

COVID-19 Vaccine Collaborative Supply Planning: Is This the Next Frontier for Routine Immunization Supply Chains?

Laila Akhlaghi1, Wendy Prosser2, Avotiana Rakotomanga3

  • 1John Snow, Inc., Arlington, VA, USA.

Global Health, Science and Practice
|February 20, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

The Vaccine Collaborative Supply Planning (VCSP) Initiative improved COVID-19 vaccine rollout by enhancing supply chain visibility and fostering collaboration. This approach strengthens vaccine forecasting and planning for future health programs.

More Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.8K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.8K

Related Experiment Videos

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
06:27

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform

Published on: October 20, 2020

5.2K
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.8K
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

1.8K

Area of Science:

  • Global Health
  • Supply Chain Management
  • Vaccinology

Background:

  • COVID-19 pandemic highlighted challenges in vaccine supply chain visibility for low- and middle-income countries.
  • Constrained global supply, uncertain timelines, and unknown demand complicated vaccine introduction planning.

Purpose of the Study:

  • To address critical gaps in COVID-19 vaccine supply and demand visibility.
  • To improve vaccine supply planning through data utilization and collaborative models.
  • To establish a framework for governments and partners in vaccine introduction.

Main Methods:

  • The Vaccine Collaborative Supply Planning (VCSP) Initiative was implemented in 15 countries starting September 2021.
  • Strategic partnerships were formed with government immunization programs and 7 organizations.
  • The initiative focused on using supply chain data for forecasting and establishing a collaborative planning model.

    • Main Results:

    • Enhanced visibility into vaccine stock status and product expiry risks.
    • Improved ability to triangulate service delivery and stock data for informed decisions.
    • Facilitated tracking of consumption patterns, scenario forecasting, and adaptive learning.

    Conclusions:

    • The VCSP Initiative successfully applied best practices in supply planning and fostered collaboration.
    • Challenges included political influences and data quality, but adaptive learning addressed these.
    • The approach offers valuable lessons for strengthening forecasting and supply planning for all vaccines during integration into routine services.